These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Status and duration of vaccination protection against tetanus in children. Evaluation of anamnestic data in relation to antibody demonstration by indirect hemagglutination]. Mai K, Bartelheimer HK, Rosin H. Dtsch Med Wochenschr; 1970 May 08; 95(19):1044-50. PubMed ID: 5424950 [No Abstract] [Full Text] [Related]
47. [Effectiveness of aerosol revaccination against tetanus in relation to the schemes and methods of primary immunization]. Egorova NB, Miroshnichenko IV, Vorontsova IV, Bikulov IM. Zh Mikrobiol Epidemiol Immunobiol; 1971 Jan 08; 48(1):90-4. PubMed ID: 5553633 [No Abstract] [Full Text] [Related]
52. Revaccination against tetanus 17 to 20 years after primary vaccination: kinetics of antibody response. Simonsen O, Klaerke M, Jensen JE, Kjeldsen K, Hau C, Heron I. J Trauma; 1987 Dec 08; 27(12):1358-61. PubMed ID: 3694727 [Abstract] [Full Text] [Related]
53. The serological assessment of a tetanus toxoid field trial. Newell KW, Leblanc DR, Edsall G, Levine L, Christensen H, Montouri MH, Ramirez N. Bull World Health Organ; 1971 Dec 08; 45(6):773-85. PubMed ID: 4947832 [Abstract] [Full Text] [Related]
57. Tetanus immunisation. Hickling S. N Z Med J; 1977 Dec 14; 86(601):529-30. PubMed ID: 272575 [No Abstract] [Full Text] [Related]
58. Impaired avidity maturation after tetanus toxoid booster in children with Down syndrome. Kusters MA, Jol-van der Zijde CM, van Tol MJ, Bolz WE, Bok LA, Visser M, de Vries E. Pediatr Infect Dis J; 2011 Apr 14; 30(4):357-9. PubMed ID: 21057373 [Abstract] [Full Text] [Related]